stella
beta
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma — Stella
Recruiting
Back to Nasopharyngeal Carcinoma trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong
View full record on ClinicalTrials.gov